INSIGHTS ON SOLID DOSE MANUFACTURING

• Contract Pharma 2026: Mikart On CDMO Collaboration

  An overview of a milestone pharmaceutical outsourcing conference focused on CDMO collaboration, tech transfer, and oral solid and liquid dose manufacturing strategies.

   

• HPAPI Containment: A Full Lifecycle Safety Innovation

  Containing highly potent APIs across a full operational lifecycle requires a structured approach that addresses hazard scoring, quality by design, performance testing, and safe enclosure disposal.

• Improving Bioavailability Through Predictive Modeling Of Solubility Enhancement Strategies

  In silico modeling cut through formulation guesswork for a compound with 0.015 mg/mL solubility, delivering an 8× Cmax and 5× AUC improvement and Phase I progression.

• Converting From A Spray-Dried Dispersion To A KinetiSol Formulation In <5 Months

  A development team quickly turned a low‑bioavailability, high‑burden formulation into a streamlined, clinically improved version, boosting exposure, simplifying manufacturing, and accelerating progress.

• A Powerful Non-Destructive Tool For Tablet Characterization

  10/6/2025

  Discover how X-ray micro-CT provides vital, non-destructive analysis of a tablet’s internal 3D physical structure. This structural insight is essential for troubleshooting defects and confirming performance.

• High Potency APIs And The Evolving Demands Of Drug Development

  4/13/2026

  See how higher API activity is changing expectations around containment, scalability, and cross‑functional alignment — and why early decisions now have a greater impact on long‑term success.

• Ask Us Anything: Jillian Sheeran On Emerging Reactor Technologies

  7/23/2026

  Jillian Sheeran, Associate Director of Engineering at Snapdragon Chemistry, on how automation, feedback control, and machine learning are changing reactor design — with real-time monitoring that lets a process run continuously while the data comes to you.

• 6 Strategic Pillars For Selecting A Drug Packaging Partner

  4/14/2026

  Early engagement with an expert packaging partner supports safe, cost-effective drug development and logistical success from precommercial stages through full market launch.

• HPAPIS Production: "Where Micrograms Matters"

  4/13/2026

  In HPAPI manufacturing, micrograms make a difference. Risk‑based containment, smart facility design, and exposure limits safeguard people, product, and performance.